"Left untreated, nephrotic syndrome may lead to end stage renal disease, which typically requires life-long dialysis treatments."
Insurance Cos: Dialysis Cost Extravagant, Acthar Saves Huge Percent.
MasterShortSeller makin dumbaz comments all over ymb, totally unrelated to everything.
200 DMA $49.05, bounced off Low $49.37 intraday, closed $51.69 on 9 Dec 2012.
Trading up every day since 9 Dec. Does this convert into a trend? No confirmation yet.
6-8M of the 9M is mostly Short Funds/ETFs that have been there since 2011 and will prob always be there.
Some of the newest Short Funds/ETFs are 2X & 3X Short, so that could explain the 9M.
The idea that Short Funds/ETFs are ALL in under $50 is Ludicrous, they do cover on a sag,
unlike Retail Short/Dumbaz/Follower/Believers whose leaders leave 'em holding the bag.
How will you know who "reads" or "thumbs down" Master Short Seller? I, for one , have iggied him.
One way for the Government to investigate Citron is to pretend to be investigating QCOR.
Remember the announcement was made right after Citron drove Q's pps down last year.
I see a new bottom on 9 Dec at 49.37. 16 out of 18 Upper indicators flat to falling & 32 out of 40 Lower Indicators flat to rising. Improvement needed.
Calls are very expensive so I did Call Ratio Backspread. Sold a 19APR $45 covered Call @ $14 & bot 2 APR $60s @ 7.40, the cost was 0.80 w/1 transaction fee.
I think it's because owners of Shorted Shares can't be disclosed according to Law, but the SEC has the authority to look into it. -Follow the money